AnaptysBio
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $27,488 | $25,556 | $108,249 | $76,320 |
Gross Profit | 30,192 | 24,946 | 216,237 | 44,913 |
EBITDA | 15,032 | -31,375 | 70,012 | 38,238 |
EBIT | 14,674 | -31,985 | 69,406 | 37,628 |
Net Income | 183,880 | -52,884 | 49,614 | 15,113 |
Net Change In Cash | 27,488 | 25,556 | 108,249 | 76,320 |
Free Cash Flow | -26,623 | -25,936 | 97,996 | -27,368 |
Cash | 133,826 | 248,469 | 238,196 | 109,833 |
Basic Shares | 35,975 | 28,691 | 31,343 | 29,018 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $234,603 | $91,280 | $17,157 | $10,287 |
Gross Profit | 232,180 | -72,560 | -115,126 | -78,511 |
EBITDA | 69,248 | -92,744 | -154,696 | -105,257 |
EBIT | 66,825 | -95,141 | -157,072 | -107,592 |
Net Income | -13,232 | -145,231 | -163,619 | -128,723 |
Net Change In Cash | 234,603 | 91,280 | 17,157 | 10,287 |
Cost of Revenue | -424,421 | |||
Free Cash Flow | 19,610 | -135,695 | -121,607 | -73,951 |
Cash | 238,196 | 123,080 | 35,965 | 71,308 |
Basic Shares | 31,343 | 28,382 | 26,924 | 28,165 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.11 |
2026-03-31 | -$1.84 |
2025-12-31 | $1.58 |
2025-09-30 | $0.52 |